Related Articles
-
September 05, 2024
CMS Updates Coverage with Evidence Development Guidance Documents
-
September 04, 2024
Feds Issue Information Notice Regarding Radiopharmaceutical Therapies
-
August 29, 2024
FDA Releases Final Guidance For MQSA Regulation Changes Effective Sept. 10
-
August 22, 2024
ACR Provides Detailed Summary of 2024 Transitional Coverage For Emerging Technologies Final Notice